Back to Search
Start Over
Konservative und medikamentöse Therapie des benignen Prostatasyndroms: Die deutsche S2e-Leitlinie 2023 – Teil 2.
- Source :
- Die Urologie; Oct2023, Vol. 62 Issue 10, p1048-1056, 9p
- Publication Year :
- 2023
-
Abstract
- <i>Copyright of Die Urologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
- Subjects :
- URINARY tract infection diagnosis
URINARY tract infection treatment
CONSERVATIVE treatment
ADRENERGIC alpha blockers
COMBINATION drug therapy
URINARY tract infections
TREATMENT effectiveness
MEDICAL protocols
SYNTHETIC drugs
PHYTOCHEMICALS
BENIGN prostatic hyperplasia
COMBINED modality therapy
OXIDOREDUCTASES
PHOSPHODIESTERASE inhibitors
MUSCARINIC antagonists
CHEMICAL inhibitors
DISEASE complications
Subjects
Details
- Language :
- German
- ISSN :
- 27317064
- Volume :
- 62
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Die Urologie
- Publication Type :
- Academic Journal
- Accession number :
- 172916549
- Full Text :
- https://doi.org/10.1007/s00120-023-02183-5